연구 보고서
publication39_tech_2007_6.pdf
개요
생명공학은 21세기 경제성장을 주도할 핵심 산업으로 부각되고 있으며, 우리가 당면하고 있는 인류 공통의 과제들을 해결할 수 있는 도구와 방법을 제공할 수 있으리라 기대하고 있습니다. 이에 서구 선진국들은 지난 수십 년간 생명공학을 핵심전략기술이라 판단하고 연구 및 기술개발에 대한 투자를 점차적으로 늘려왔으며 핵심원천기술 개발을 위한 각국의 경쟁이 매우 치열한 분야라고 할 수 있습니다.
이에 생명공학정책연구센터에서는 BT 핵심기술들을 선별하여 이러한 BT 핵심기술들에 대한 특허, 논문 및 시장정보 분석과 국내 외 총괄 기술발전도를 작성하여 관련 분야의 기술개발 동향을 한 눈에 파악할 수 있도록 정리하고자 “BT 기술동향 보고서”를 주기적으로 발간하고 있습니다. BT분야 핵심기술 동향보고서 발간을 통하여 제공되는 국가 BT 정책 추진현황 및 R&D 활동현황, 국내외 BT 동향과 전망 등에 대한 체계적인 정보는 생명공학 전문가, 관련 기업, 그리고 정부의 생명공학 정책입안자들에게 유용한 정책자료로 활용될 수 있을 것으로 기대합니다.
본 보고서는 39번째로 발간되는 생명공학정책연구센터 총서이며 11번째로 발간되는 기술동향 보고서로서 “글라이코믹스 및 탄수화물 의약품”에 대한 내용을 담고 있습니다. 관련 기술분야 전문가들이 연구를 수행함에 있어 미약하나마 도움이 되시길 바라며 앞으로 보다 양질의 분석자료를 제공하도록 노력 겠습니다.
끝으로 본 보고서 작성을 위해 아낌없는 지원을 해주신 과학기술부 관계자를 비롯하여 많은 조언과 지도를 해주신 성균관대학교의 김철호 교수님, 기초과학지원연구원 김수현 박사님, 생명공학연구원 강현아 박사님과 고정헌 박사님께도 심심한 감사의 말씀을 드립니다.
2007. 6
국가생명공학정책연구센터장 현 병 환
목차
1. 기술개요 ··············································································································1
가. 정의 및 특징 ······································································································1
나. 환경변화 ··············································································································3
다. 글라이코믹스 관련 정보사이트 ········································································5
2. 서지분석 ··············································································································6
가. 특허 및 논문분석을 위한 기술분류 체계 및 검색 범위 ······························6
1) 기술분야의 범위 및 정의 ·················································································6
2) 기술분류 및 검색키워드 ···················································································7
나. 특허분석 ··············································································································8
1) 특허로 살펴본 글라이코믹스 및 탄수화물 의약품 세계동향 ······················8
2) 특허로 살펴본 글라이코믹스 및 탄수화물 의약품 국내동향 ····················11
다. 논문분석 ············································································································13
1) 논문으로 살펴본 글라이코믹스 및 탄수화물 의약품 세계동향 ················13
2) 논문으로 살펴본 글라이코믹스 및 탄수화물 의약품 국내동향 ················15
라. 시장성 분석 관련 산업동향 ········································································17
3. 기술개발 동향 ································································································23
가. 세계동향 ············································································································23
1) 대표적인 국제 컨소시움 및 국가별 전문 연구기관 ···································23
2) 주요 연구자 ·····································································································25
3) 주요 기업 ·········································································································26
나. 국내동향 ············································································································29
1) 관련 수행과제 ··································································································29
2) 주요 연구자 및 연구활동 ···············································································30
4. 국내외 기술수준비교 ··················································································33
가. 기술수준비교 ····································································································33
나. SWOT 분석 ······································································································34
5. 기대효과 ············································································································35
가. 기술 사회적 효과 ·························································································35
나. 경제 산업적 효과 ·························································································35
6. 참고문헌 ············································································································36
별첨 1. 글라이코믹스 및 탄수화물 의약품 분야 특허분석
별첨 2. 글라이코믹스 및 탄수화물 의약품 분야 논문분석
-
이전글
- 유전체 연구 및 활용기술
-
다음글
- 시스템 생물학